These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 3006246)
1. Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein. Kennedy RC; Henkel RD; Pauletti D; Allan JS; Lee TH; Essex M; Dreesman GR Science; 1986 Mar; 231(4745):1556-9. PubMed ID: 3006246 [TBL] [Abstract][Full Text] [Related]
2. Envelope proteins of human T cell leukemia virus type I: characterization by antisera to synthetic peptides and identification of a natural epitope. Copeland TD; Tsai WP; Kim YD; Oroszlan S J Immunol; 1986 Nov; 137(9):2945-51. PubMed ID: 2428880 [TBL] [Abstract][Full Text] [Related]
3. Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. Allan JS; Coligan JE; Barin F; McLane MF; Sodroski JG; Rosen CA; Haseltine WA; Lee TH; Essex M Science; 1985 May; 228(4703):1091-4. PubMed ID: 2986290 [TBL] [Abstract][Full Text] [Related]
4. Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients. Barin F; McLane MF; Allan JS; Lee TH; Groopman JE; Essex M Science; 1985 May; 228(4703):1094-6. PubMed ID: 2986291 [TBL] [Abstract][Full Text] [Related]
5. Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization. Tanaka Y; Zeng L; Shiraki H; Shida H; Tozawa H J Immunol; 1991 Jul; 147(1):354-60. PubMed ID: 1711082 [TBL] [Abstract][Full Text] [Related]
6. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46. Palker TJ; Tanner ME; Scearce RM; Streilein RD; Clark ME; Haynes BF J Immunol; 1989 Feb; 142(3):971-8. PubMed ID: 2563272 [TBL] [Abstract][Full Text] [Related]
7. Detection of antibodies to human T-lymphotropic virus type III by using a synthetic peptide of 21 amino acid residues corresponding to a highly antigenic segment of gp41 envelope protein. Wang JJ; Steel S; Wisniewolski R; Wang CY Proc Natl Acad Sci U S A; 1986 Aug; 83(16):6159-63. PubMed ID: 2426711 [TBL] [Abstract][Full Text] [Related]
8. An HTLV-III peptide produced by recombinant DNA is immunoreactive with sera from patients with AIDS. Chang NT; Huang J; Ghrayeb J; McKinney S; Chanda PK; Chang TW; Putney S; Sarngadharan MG; Wong-Staal F; Gallo RC Nature; 1985 May 9-15; 315(6015):151-4. PubMed ID: 2986016 [TBL] [Abstract][Full Text] [Related]
9. Delineation of type-specific regions on the envelope glycoproteins of human T cell leukemia viruses. Chen YM; Zhang XQ; Dahl CE; Samuel KP; Schooley RT; Essex M; Papas TS J Immunol; 1991 Oct; 147(7):2368-76. PubMed ID: 1717557 [TBL] [Abstract][Full Text] [Related]
10. Immune response to human immunodeficiency virus. In vivo administration of anti-idiotype induces an anti-gp160 response specific for a synthetic peptide. Zhou EM; Chanh TC; Dreesman GR; Kanda P; Kennedy RC J Immunol; 1987 Nov; 139(9):2950-6. PubMed ID: 3668251 [TBL] [Abstract][Full Text] [Related]
11. Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein. Lasky LA; Groopman JE; Fennie CW; Benz PM; Capon DJ; Dowbenko DJ; Nakamura GR; Nunes WM; Renz ME; Berman PW Science; 1986 Jul; 233(4760):209-12. PubMed ID: 3014647 [TBL] [Abstract][Full Text] [Related]
12. Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III). Fischinger PJ; Robey WG; Koprowski H; Gallo RC; Bolognesi DP Cancer Res; 1985 Sep; 45(9 Suppl):4694s-4699s. PubMed ID: 2410115 [TBL] [Abstract][Full Text] [Related]
13. Human monoclonal antibody directed against an envelope glycoprotein of human T-cell leukemia virus type I. Matsushita S; Robert-Guroff M; Trepel J; Cossman J; Mitsuya H; Broder S Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2672-6. PubMed ID: 2422659 [TBL] [Abstract][Full Text] [Related]
14. Antigens on HTLV-infected cells recognized by leukemia and AIDS sera are related to HTLV viral glycoprotein. Schüpbach J; Sarngadharan MG; Gallo RC Science; 1984 May; 224(4649):607-10. PubMed ID: 6324349 [TBL] [Abstract][Full Text] [Related]
15. Serological characterization of human T-cell leukemia (lymphotropic) virus, type I (HTLV-I) small envelope protein. Newman MJ; Baker IT; Reitz MS; Eiden M; Blattner WA; Gallo RC; Mann DL Virology; 1986 Apr; 150(1):106-16. PubMed ID: 3006330 [TBL] [Abstract][Full Text] [Related]
16. Retroviruses associated with leukemia and ablative syndromes in animals and in human beings. Essex M; McLane MF; Kanki P; Allan J; Kitchen L; Lee TH Cancer Res; 1985 Sep; 45(9 Suppl):4534s-4538s. PubMed ID: 2990682 [TBL] [Abstract][Full Text] [Related]
17. Human T-cell lymphotropic virus type III: immunologic characterization and primary structure analysis of the major internal protein, p24. Casey JM; Kim Y; Andersen PR; Watson KF; Fox JL; Devare SG J Virol; 1985 Aug; 55(2):417-23. PubMed ID: 2410630 [TBL] [Abstract][Full Text] [Related]
18. A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients. Allan JS; Coligan JE; Lee TH; McLane MF; Kanki PJ; Groopman JE; Essex M Science; 1985 Nov; 230(4727):810-3. PubMed ID: 2997921 [TBL] [Abstract][Full Text] [Related]
19. Synthetic peptides derived from the deduced amino acid sequence of the E-glycoprotein of Murray Valley encephalitis virus elicit antiviral antibody. Roehrig JT; Hunt AR; Johnson AJ; Hawkes RA Virology; 1989 Jul; 171(1):49-60. PubMed ID: 2472704 [TBL] [Abstract][Full Text] [Related]
20. A glycopolypeptide (gp 100) is the main antigen detected by HTLV-III antisera. Schneider J; Bayer H; Bienzle U; Hunsmann G Med Microbiol Immunol; 1985; 174(1):35-42. PubMed ID: 2987654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]